Acute dystonia during pegylated interferon alpha therapy in a case with chronic hepatitis B infection

Interferon (IFN) is the most widely prescribed drug of choice for chronic hepatitis B infection, which is a common health problem in our country. Therapy with IFN-alpha may be associated with a number of neuropsychiatric symptoms, such as Parkinsonism, akathisia, seizure, and depressive disorders. In this case report, we present clinical and laboratory findings of a case with chronic hepatitis B that developed acute dystonia soon after the first dose of pegylated interferon alpha. As far as we know, this is the first report in English literature indicating such an adverse effect of pegylated interferon alpha.

Yazar Atasoy, N
Ustundag, Y
Konuk, N
Atik, L
Yayın Türü Review
Tek Biçim Adres https://hdl.handle.net/20.500.12628/2019
Tek Biçim Adres 10.1097/00002826-200405000-00002
Koleksiyonlar Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed | SOBİAD
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu
Sayfalar 105 - 107
Yayın Yılı 2004
Eser Adı
[dc.title]
Acute dystonia during pegylated interferon alpha therapy in a case with chronic hepatitis B infection
Yayın Yılı
[dc.date.issued]
2004
Yayıncı
[dc.publisher]
LIPPINCOTT WILLIAMS & WILKINS
Yayın Türü
[dc.type]
review
Açıklama
[dc.description]
WOS: 000222099200002
Açıklama
[dc.description]
PubMed: 15190230
Özet
[dc.description.abstract]
Interferon (IFN) is the most widely prescribed drug of choice for chronic hepatitis B infection, which is a common health problem in our country. Therapy with IFN-alpha may be associated with a number of neuropsychiatric symptoms, such as Parkinsonism, akathisia, seizure, and depressive disorders. In this case report, we present clinical and laboratory findings of a case with chronic hepatitis B that developed acute dystonia soon after the first dose of pegylated interferon alpha. As far as we know, this is the first report in English literature indicating such an adverse effect of pegylated interferon alpha.
Tek Biçim Adres
[dc.identifier.uri]
https://dx.doi.org/10.1097/00002826-200405000-00002
Tek Biçim Adres
[dc.identifier.uri]
https://hdl.handle.net/20.500.12628/2019
Yayın Dili
[dc.language.iso]
eng
Yazar
[dc.contributor.author]
Atasoy, N
Yazar
[dc.contributor.author]
Ustundag, Y
Yazar
[dc.contributor.author]
Konuk, N
Yazar
[dc.contributor.author]
Atik, L
Haklar
[dc.rights]
info:eu-repo/semantics/closedAccess
İlk Sayfa Sayısı
[dc.identifier.startpage]
105
Son Sayfa Sayısı
[dc.identifier.endpage]
107
Açık Erişim Tarihi
[dc.date.available]
2019-12-23
Görüntülenme Sayısı ( Şehir )
Görüntülenme Sayısı ( Ülke )
Görüntülenme Sayısı ( Zaman Dağılımı )
Görüntülenme
9
09.12.2022 tarihinden bu yana
İndirme
1
09.12.2022 tarihinden bu yana
Son Erişim Tarihi
08 Şubat 2024 01:16
Google Kontrol
Tıklayınız
interferon pegylated report hepatitis chronic findings effect adverse present clinical laboratory indicating literature developed dystonia English Interferon Parkinsonism widely prescribed choice infection common health problem country disorders Therapy IFN-alpha associated number neuropsychiatric symptoms akathisia seizure
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms